Clinical trial
A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum…
NCT00006072 · National Center for Research Resources (NCRR), NIH · Unknown status
Key facts
| NCT number | NCT00006072 |
|---|---|
| Title | A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum IgM Autoantibodies |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | Genentech, Inc. Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Peripheral Neuropathy |
| Intervention type | Drug |
| Interventions | Rituxan |
| First posted | Jul 26, 2000 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: